These numbers demonstrate the importance of colorectal cancer screenings.  With colorectal cancer screenings, physicians often are able to detect precancerous polyps and early-stage malignant tumors when they are the most easily treated.

Patients who do not have symptoms or an increased risk of colorectal cancer are usually advised to begin regular screenings at age 50.  LMHS offers four types of colorectal screening tests: colonoscopy, flexible sigmoidoscopy, high-sensitivity fecal occult blood test and Cologuard® at-home kits that test the patient’s DNA and detects the presence of blood in the stool.

Colonoscopy allows the gastroenterologist to view the entire large intestine while the patient usually is sedated.  It is considered to be the “gold standard” of colon cancer screening methods because the physician is able to see any abnormalities directly.  In addition, the physician may be able to remove polyps, if present, during the procedure.

Although colonoscopy provides the most accurate assessment of a patient’s colon health, Licking Memorial Health Systems’ physicians have a new option that they can prescribe.  The Cologuard kit received FDA approval in 2014 as a colorectal cancer screening tool for patients who are considered to be at average risk (see Health Tips – Risk Factors for Colorectal Cancer on page 20), and are not experiencing any symptoms of colorectal cancer, such as: blood in or on the stool, constant stomach pain, and unexplained weight loss.  With Cologuard, the patient collects stool samples at home and sends them to a testing laboratory.  Patients who have any questions about colorectal cancer screening options should consult their primary care physician.